The Journal of Pharmacology: PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and

June 20, 2019
Previous Flipbook
B - Editorial T. Wong: Blood Journal Plasminogen
B - Editorial T. Wong: Blood Journal Plasminogen

Next Flipbook
JCI insight: Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control
JCI insight: Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control